Medite Cancer DiagnosticsMDIT
13F holders, Q1 2026 (March 31)2holders
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q1 2026, 2 institutions reported holding Medite Cancer Diagnostics Inc. (MDIT) in their 13F filings, unchanged from Q4 2025. 0 opened new positions and 0 sold out. The largest holders were Ancora Advisors LLC ($0) and Sfam, LLC ($0).
- Company
- Medite Cancer Diagnostics Inc.
- CUSIP
- 58503D200
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 2 holders
| Ancora Advisors LLC | 0.00% | No change | 30 | $0 |
| Sfam, LLC | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is MDIT's weight in each manager's 13F, not the share of Medite Cancer Diagnostics Inc. the manager owns.